Knowing Your Options
Spravato or IV Ketamine. Which option best fits your needs and treatment goals?
New Year 2026 Bundle
Starting care can feel like a big change. To make it a little easier to get started, we’re offering the following for patients who begin treatment in January:
-
$450 off your ketamine treatment series
-
Two complimentary integration sessions
-
50% off any vitamin services you choose to add
This limited-time offer is our way of reducing barriers and supporting patients as they begin their healing journey without pressure, obligation, or expectations.
Breakthrough relief is closer than you think.
When therapy and medications haven’t quieted anxiety, IV ketamine may help—safe, effective, and personalized.
45,000+ Infusions delivered
Spravato vs. IV Ketamine
What’s the difference really?
Spravato and IV ketamine are two different ways to receive ketamine-based treatment. Spravato is an FDA-approved nasal spray that’s often covered by insurance, but your body absorbs less of the medication. IV ketamine is delivered directly into your bloodstream, providing a more predictable, controlled experience. Both options can be effective; the right fit depends on your symptoms, goals, and whether you prefer an insurance-covered nasal spray or the precision of IV infusions.
What is bioavailability?
Bioavailability describes how much of a medication your body actually absorbs and can use. For SPRAVATO, the esketamine nasal spray, the average bioavailability is about 48%, meaning only about half of the dose enters your bloodstream after administration. That’s significantly less than an IV ketamine infusion, which delivers the medication directly into your bloodstream for near-100% bioavailability. Because IV delivery bypasses absorption barriers, it ensures a more predictable, consistent, and dosing.
Will I see results from Spravato?
Studies show that Spravato helps a significant number of patients with treatment-resistant depression: response rates (meaning a meaningful reduction in symptoms) fall roughly in the 50-60% range. This means 50-60% of patients find relief.
If you’re looking for substantial relief, many studies report 80% of patients who receive IV ketamine will experience this often within hours or days and complete remission rates reach a notable portion of patients.
What have the experts seen?
A study conducted in 2023 that was presented at the American Psychiatric Association (APA) annual meeting and published in the New England Journal of Medicine showed IV Ketamine matching the ‘gold standard’ in major depression treatment. The ketamine participants had a 14.2% treatment difference in the trial when compared to ECT which has been the previous gold standard for 80 years.
When patients choose IV instead of Spravato:
When standard care isn’t enough, in‑clinic ketamine treatment may help reduce persistent symptoms of depression, anxiety, or PTSD. Our local clinicians deliver monitored infusions with careful dosing and follow‑up support.
-
Higher Bioavailability: Higher bioavailability = more predictable and consistent results.
-
More Controlled and Adjustable Dosing: With infusions, your provider can adjust the dose in real time based on your response, symptoms, side effects, and more. This level of precision isn’t possible with nasal spray.
-
Faster Relief: Infusions are known for rapid onset, many patients feel improvement within hours to days. Spravato often takes multiple weeks before effects build.
-
Strong Clinical Research Track Record: IV Ketamine has been studied since the early 2000s and has decades of anesthesia data behind it. Spravato has newer data, with fewer long-term studies.
-
Some Patients Don’t Respond: A common pattern: people who try Spravato but don’t get the results they were hoping for often respond to IV infusions afterward.
What to Expect
Consultation
Meet with our clinical team to review your history, medications, and goals. We’ll confirm if in‑clinic ketamine is appropriate and outline a plan.
In-Clinic Infusions
Receive your infusion in a quiet, controlled setting with continuous monitoring. Initial treatment series include six sessions over a few weeks.
Feel Better. Finally.
Experience treatment in a calming, private setting - with expert staff by your side. Most patients report a major shift within the first 1–3 weeks.
What people think
Don’t just take our word for it. These are real and current Google Reviews, not a curated version of what we want you to see.
Ready to talk about options?
If your symptoms keeps interfering with your life, there’s another option. Our care team can walk you through everything—no pressure, just answers. Let’s talk.
Request your free consultation today
Talk to one of our experts to help you identify which program works best for you. We will reach out to you right away.
Mental Health and Chronic Pain Treatments in Bellevue, Seattle, and Tacoma
Addiction Treatment and Substance Use Provided at our Bellevue Location